Synonym
Albuterol stearate
IUPAC/Chemical Name
Octadecanoic acid--4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol (1/1)
InChi Key
CPEOPCFQCPEQML-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H36O2.C13H21NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h2-17H2,1H3,(H,19,20);4-6,12,14-17H,7-8H2,1-3H3
SMILES Code
OC1=CC=C(C(CNC(C)(C)C)O)C=C1CO.CCCCCCCCCCCCCCCCCC(O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
523.80
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Stank K, Steckel H. Physico-chemical characterisation of surface modified particles for inhalation. Int J Pharm. 2013 May 1;448(1):9-18. doi: 10.1016/j.ijpharm.2013.03.009. Epub 2013 Mar 18. PubMed PMID: 23518364.
2: Tuli RA, George GA, Dargaville TR, Islam N. Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations. Pharm Res. 2012 Sep;29(9):2445-55. doi: 10.1007/s11095-012-0772-y. Epub 2012 May 15. Erratum in: Pharm Res. 2013 Jan;30(1):303. PubMed PMID: 22584947.
3: Tuli RA, Dargaville TR, George GA, Islam N. Polycaprolactone microspheres as carriers for dry powder inhalers: effect of surface coating on aerosolization of salbutamol sulfate. J Pharm Sci. 2012 Feb;101(2):733-45. doi: 10.1002/jps.22777. Epub 2011 Sep 28. PubMed PMID: 21956254.
4: Zhou QT, Qu L, Larson I, Stewart PJ, Morton DA. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach. Int J Pharm. 2010 Jul 15;394(1-2):50-9. doi: 10.1016/j.ijpharm.2010.04.032. Epub 2010 May 7. PubMed PMID: 20435112.
5: Huang WH, Yang ZJ, Wu H, Wong YF, Zhao ZZ, Liu L. Development of liposomal salbutamol sulfate dry powder inhaler formulation. Biol Pharm Bull. 2010;33(3):512-7. PubMed PMID: 20190418.
6: Balani PN, Ng WK, Tan RB, Chan SY. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives. J Pharm Sci. 2010 May;99(5):2462-74. doi: 10.1002/jps.21998. PubMed PMID: 19902526.
7: Tay T, Das S, Stewart P. Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism? Int J Pharm. 2010 Jan 4;383(1-2):62-9. doi: 10.1016/j.ijpharm.2009.09.006. Epub 2009 Sep 11. PubMed PMID: 19748561.
8: Begat P, Morton DA, Shur J, Kippax P, Staniforth JN, Price R. The role of force control agents in high-dose dry powder inhaler formulations. J Pharm Sci. 2009 Aug;98(8):2770-83. doi: 10.1002/jps.21629. PubMed PMID: 19067395.
9: Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier. Chem Pharm Bull (Tokyo). 2004 Apr;52(4):444-6. PubMed PMID: 15056961.
10: Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Chem Pharm Bull (Tokyo). 2004 Mar;52(3):350-3. PubMed PMID: 14993760.
11: Govender T, Dangor CM. Formulation and preparation of controlled release pellets of salbutamol by the air suspension technique. J Microencapsul. 1997 Jul-Aug;14(4):445-55. PubMed PMID: 9229344.
12: Jashnani RN, Dalby RN, Byron PR. Preparation, characterization, and dissolution kinetics of two novel albuterol salts. J Pharm Sci. 1993 Jun;82(6):613-6. PubMed PMID: 8331536.
